Medicamen Organics Makes Preferential Allotment of Convertible Warrants to Promoter

New Delhi, March 18, 2025 – Medicamen Organics Limited (MOL) (NSE- MEDIORG), is pleased to announce the successful allotment of 4,65,910 fully convertible warrants on a preferential basis to Mr. Bal Kishan Gupta, a promoter of the Company. Each warrant is issued at ₹64.39 and will be convertible into an equivalent number of equity shares of ₹10 each within 18 months from the date of allotment. The payment structure requires 25% of the warrant price to be paid at the time of allotment, with the remaining 75% payable upon conversion.

This strategic fund infusion underscores the promoter’s confidence in the Company’s future growth prospects. The capital raised through this preferential allotment will serve as a key enabler in achieving Medicamen Organics’ expansion objectives and strengthening its market position.

Commenting on the development, Mr. Bal Kishan Gupta, Managing Director said, ” “The pharmaceutical industry continues to grow steadily, and this capital infusion will enable us to leverage emerging opportunities while ensuring financial prudence. As a promoter, I remain highly confident in Medicamen Organics’ future prospects. With this financial backing, we are committed to enhancing our competitive edge and delivering high-quality pharmaceutical solutions to the market. The Company remains focused on strategic growth, operational efficiency, and value creation for its stakeholders.”